Structure

Physi-Chem Properties

Molecular Weight:  561.21
Volume:  556.328
LogP:  4.387
LogD:  2.393
LogS:  -3.479
# Rotatable Bonds:  4
TPSA:  166.95
# H-Bond Aceptor:  11
# H-Bond Donor:  5
# Rings:  5
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.122
Synthetic Accessibility Score:  5.626
Fsp3:  0.333
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.829
MDCK Permeability:  1.3703343029192183e-05
Pgp-inhibitor:  0.609
Pgp-substrate:  0.971
Human Intestinal Absorption (HIA):  0.949
20% Bioavailability (F20%):  0.944
30% Bioavailability (F30%):  0.421

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.004
Plasma Protein Binding (PPB):  94.49927520751953%
Volume Distribution (VD):  0.857
Pgp-substrate:  8.142524719238281%

ADMET: Metabolism

CYP1A2-inhibitor:  0.028
CYP1A2-substrate:  0.342
CYP2C19-inhibitor:  0.068
CYP2C19-substrate:  0.08
CYP2C9-inhibitor:  0.852
CYP2C9-substrate:  0.787
CYP2D6-inhibitor:  0.2
CYP2D6-substrate:  0.149
CYP3A4-inhibitor:  0.288
CYP3A4-substrate:  0.917

ADMET: Excretion

Clearance (CL):  7.425
Half-life (T1/2):  0.821

ADMET: Toxicity

hERG Blockers:  0.014
Human Hepatotoxicity (H-HT):  0.837
Drug-inuced Liver Injury (DILI):  0.974
AMES Toxicity:  0.051
Rat Oral Acute Toxicity:  0.744
Maximum Recommended Daily Dose:  0.643
Skin Sensitization:  0.947
Carcinogencity:  0.226
Eye Corrosion:  0.003
Eye Irritation:  0.107
Respiratory Toxicity:  0.804

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC161644

Natural Product ID:  NPC161644
Common Name*:   Renieramycin S
IUPAC Name:   n.a.
Synonyms:   Renieramycin S
Standard InCHIKey:  FSDHSSHYVUZGFT-INUIFXHSSA-N
Standard InCHI:  InChI=1S/C30H31N3O8/c1-7-12(2)30(39)41-11-20-21-15(24(34)13(3)26(36)27(21)37)9-18-23-22-16(25(35)14(4)29(40-6)28(22)38)8-17(32(23)5)19(10-31)33(18)20/h7,17-20,23,36H,8-9,11H2,1-6H3/b12-7-/t17-,18-,19-,20-,23-/m0/s1
SMILES:  C/C=C(/C)C(=O)OC[C@H]1C2=C(C[C@H]3[C@H]4C5=C(C[C@@H]([C@H](C#N)N13)N4C)C(=O)C(=C(C5=O)OC)C)C(=O)C(=C(C2=O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL468488
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0002566] Isoquinolines and derivatives
        • [CHEMONTID:0002567] Isoquinoline quinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. n.a. n.a. PMID[11908959]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. Caledonian n.a. PMID[1453184]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. Thai n.a. PMID[14640515]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. thai n.a. PMID[15217287]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. n.a. n.a. PMID[1710256]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. Indonesia n.a. PMID[20503979]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. coral reef habitat at a depth of approximately 20 m from the sea bed surface, at Sangalaki, Indonesia (2 04 59 N, 118 23 41 E) 1996-MAR PMID[20503979]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. n.a. n.a. PMID[31260310]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. Philippine n.a. PMID[7473578]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. n.a. n.a. PMID[7798966]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT393 Cell Line HCT-116 Homo sapiens IC50 = 15.0 nM PMID[458212]
NPT3558 Cell Line QG-56 IC50 = 26.0 nM PMID[458212]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC161644 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9669 High Similarity NPC97861
0.9449 High Similarity NPC25025
0.9286 High Similarity NPC473703
0.9286 High Similarity NPC239252
0.7536 Intermediate Similarity NPC313348
0.7536 Intermediate Similarity NPC475987
0.7424 Intermediate Similarity NPC315110
0.7293 Intermediate Similarity NPC13351
0.7273 Intermediate Similarity NPC473955
0.6288 Remote Similarity NPC469895
0.6267 Remote Similarity NPC82129
0.6107 Remote Similarity NPC120335
0.6084 Remote Similarity NPC230849
0.6012 Remote Similarity NPC475342
0.6 Remote Similarity NPC315011
0.5946 Remote Similarity NPC247902
0.5946 Remote Similarity NPC262880
0.5944 Remote Similarity NPC471673
0.592 Remote Similarity NPC296589
0.5912 Remote Similarity NPC271562
0.5909 Remote Similarity NPC241426
0.5882 Remote Similarity NPC133420
0.5879 Remote Similarity NPC44040
0.5878 Remote Similarity NPC309525
0.5862 Remote Similarity NPC11379
0.5857 Remote Similarity NPC181510
0.5857 Remote Similarity NPC168758
0.5857 Remote Similarity NPC47857
0.5833 Remote Similarity NPC174463
0.5833 Remote Similarity NPC235625
0.5828 Remote Similarity NPC215507
0.5828 Remote Similarity NPC41162
0.5827 Remote Similarity NPC298484
0.5806 Remote Similarity NPC45813
0.5775 Remote Similarity NPC130124
0.5775 Remote Similarity NPC193471
0.5762 Remote Similarity NPC470539
0.5758 Remote Similarity NPC475180
0.5758 Remote Similarity NPC150041
0.5753 Remote Similarity NPC88190
0.5752 Remote Similarity NPC133089
0.5736 Remote Similarity NPC473746
0.5724 Remote Similarity NPC120599
0.5724 Remote Similarity NPC200412
0.5724 Remote Similarity NPC156336
0.5714 Remote Similarity NPC120420
0.5705 Remote Similarity NPC97580
0.5695 Remote Similarity NPC173173
0.5694 Remote Similarity NPC288629
0.5677 Remote Similarity NPC99864
0.5674 Remote Similarity NPC196073
0.5674 Remote Similarity NPC195435
0.5672 Remote Similarity NPC476344
0.5672 Remote Similarity NPC265662
0.5672 Remote Similarity NPC472167
0.5652 Remote Similarity NPC211215
0.5643 Remote Similarity NPC470535
0.5629 Remote Similarity NPC476951
0.5629 Remote Similarity NPC317654
0.5629 Remote Similarity NPC96010
0.5625 Remote Similarity NPC469861
0.5625 Remote Similarity NPC130436
0.5625 Remote Similarity NPC272166
0.5625 Remote Similarity NPC469860
0.5621 Remote Similarity NPC307165
0.562 Remote Similarity NPC473289
0.5616 Remote Similarity NPC470300
0.5616 Remote Similarity NPC106791
0.5616 Remote Similarity NPC201889
0.5616 Remote Similarity NPC284656
0.5616 Remote Similarity NPC476952
0.5612 Remote Similarity NPC93179
0.5608 Remote Similarity NPC23963
0.5603 Remote Similarity NPC470536
0.56 Remote Similarity NPC469999

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC161644 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7424 Intermediate Similarity NPD7196 Clinical (unspecified phase)
0.6288 Remote Similarity NPD2259 Approved
0.6288 Remote Similarity NPD2258 Approved
0.6 Remote Similarity NPD2101 Approved
0.5986 Remote Similarity NPD4816 Clinical (unspecified phase)
0.5789 Remote Similarity NPD7260 Phase 2
0.5742 Remote Similarity NPD8387 Clinical (unspecified phase)
0.5677 Remote Similarity NPD8415 Approved
0.5676 Remote Similarity NPD2838 Clinical (unspecified phase)
0.5649 Remote Similarity NPD6845 Suspended
0.5625 Remote Similarity NPD1000 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data